BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
BridgeBio Pharma, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$67.94+1.55 (+2.33%)
Close on Oct 19, 2026
- Market cap
- $13.30B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of BridgeBio Pharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 6, 2026 | Oct 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2026 | Aug 31, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2026 | Jul 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 22, 2026 | Jun 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 27, 2026 | May 27, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 22, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 14, 2026 | Jan 21, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2025 | Oct 27, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2025 | Jul 2, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 23, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 20, 2025 | Apr 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2025 | Feb 28, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 20, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2025 | Feb 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 22, 2024 | Nov 25, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2024 | Sep 11, 2024 | SEC EDGAR |